1. Wei, Wei, Zeng, Qingxuan, Wang, Yan, Jiang, Jiandong, Song, Danqing. 2022. Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects. In Acta pharmaceutica Sinica. B, 13, 2138-2151. doi:10.1016/j.apsb.2022.12.009. https://pubmed.ncbi.nlm.nih.gov/37250154/
2. Huang, Haohao, Zhang, Songyang, Li, Yuanyuan, Xia, Qing, Man, Jianghong. 2021. Suppression of mitochondrial ROS by prohibitin drives glioblastoma progression and therapeutic resistance. In Nature communications, 12, 3720. doi:10.1038/s41467-021-24108-6. https://pubmed.ncbi.nlm.nih.gov/34140524/
3. Villa-Cedillo, Sheila Adela, Acosta-Espinoza, Esrom Jared, Soto-Domínguez, Adolfo, Valdés, Jesús, Saucedo-Cárdenas, Odila. 2024. Antioxidant PRDX3 gene therapy protects brain cells and prevents neurodegeneration in an animal model of Parkinson's disease. In Neuropeptides, 110, 102494. doi:10.1016/j.npep.2024.102494. https://pubmed.ncbi.nlm.nih.gov/39736192/
4. Wonsey, Diane R, Zeller, Karen I, Dang, Chi V. . The c-Myc target gene PRDX3 is required for mitochondrial homeostasis and neoplastic transformation. In Proceedings of the National Academy of Sciences of the United States of America, 99, 6649-54. doi:. https://pubmed.ncbi.nlm.nih.gov/12011429/
5. Zhao, Zhou, Cai, Zhaolun, Zhang, Su, Han, Junhong, Zhang, Bo. 2024. Activation of the FOXM1/ASF1B/PRDX3 axis confers hyperproliferative and antioxidative stress reactivity to gastric cancer. In Cancer letters, 589, 216796. doi:10.1016/j.canlet.2024.216796. https://pubmed.ncbi.nlm.nih.gov/38537775/
6. Liu, Zhilei, Hu, Yadong, Liang, Haisha, Feng, Shan, Deng, Haiteng. 2016. Silencing PRDX3 Inhibits Growth and Promotes Invasion and Extracellular Matrix Degradation in Hepatocellular Carcinoma Cells. In Journal of proteome research, 15, 1506-14. doi:10.1021/acs.jproteome.5b01125. https://pubmed.ncbi.nlm.nih.gov/26983019/
7. Wang, Guangyu, Wang, Bin, Qin, Qingtao, Zhao, Yuying, Lin, Pengfei. 2023. Exon Skipping Caused by Noncanonical Splicing Mutation in PRDX3-Related Spinocerebellar Ataxia. In Movement disorders : official journal of the Movement Disorder Society, 38, 1968-1970. doi:10.1002/mds.29575. https://pubmed.ncbi.nlm.nih.gov/37553955/
8. Chua, Pei-Jou, Ow, Suet-Hui, Ng, Cheng-Teng, Chan, Michael W Y, Bay, Boon-Huat. 2024. Peroxiredoxin 3 regulates breast cancer progression via ERK-mediated MMP-1 expression. In Cancer cell international, 24, 59. doi:10.1186/s12935-024-03248-x. https://pubmed.ncbi.nlm.nih.gov/38321552/